Instil Bio (NASDAQ:TIL) stock fell 15% Tuesday after the company announced that its wholly-owned subsidiary Axion Bio has decided to discontinue clinical developm ...

As Spain continues to cement its position among the world’s most dynamic exporters of scripted TV, Atresmedia Sales has unveiled a key deal with AXN Japan on detective drama “Una vida menos en ...

The Army will review the use of selection boards to assess senior soldiers for command positions, officials said. In a memo Thursday, Secretary of the Army Dan Driscoll rescinded the official status ...

Movistar Plus+ and Sony Pictures Entertainment have renewed their long-standing partnership, securing continued access for Spanish audiences to Sony’s theatrical films and television content, ...

Spanish streamer Movistar Plus+ and Sony Pictures Entertainment (SPE) have renewed their multifacted film and television series content agreement. Under the renewal, Movistar Plus+ will continue to be ...

Anticipate ImmuneOnco sharing initial safety and efficacy results from phase 2 trial of ‘2510 + chemo in 1L NSCLC in the second half of 2025 DALLAS, July 02, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. ...

Instil Bio (NASDAQ:TIL) shares moved higher after the company, alongside its partner ImmuneOnco Biopharmaceuticals, announced key updates to the clinical development strategy for their experimental PD ...

Instil Bio reports ongoing trials for AXN-2510/IMM2510 in NSCLC; financial results show cash reserves enabling operations beyond 2026. Instil Bio, Inc. announced ongoing enrollment for a clinical ...

ImmuneOnco plans to release clinical data for AXN-2510/IMM2510 in NSCLC in 2025, initiating trials in China and the U.S. Instil Bio, Inc. announced plans for the clinical development of its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.